de State Street ANI Pharmaceuticals ANIP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 68.9 M | Comprar |
831,647
+60,060
| +8% | +USD 4.82 M | ﹤0.01% | 1684 |
|
|
2026
Q1 | USD 59.3 M | Comprar |
771,587
+44,383
| +6% | +USD 3.46 M | ﹤0.01% | 1647 |
|
|
2025
Q4 | USD 57.4 M | Comprar |
727,204
+15,496
| +2% | +USD 1.34 M | ﹤0.01% | 1665 |
|
|
2025
Q3 | USD 65.2 M | Vender |
711,708
-4,409
| -0.6% | -USD 360 k | ﹤0.01% | 1596 |
|
|
2025
Q2 | USD 46.7 M | Comprar |
716,117
+1,547
| +0.2% | +USD 101 k | ﹤0.01% | 1712 |
|
|
2025
Q1 | USD 47.8 M | Vender |
714,570
-22,718
| -3% | -USD 1.36 M | ﹤0.01% | 1667 |
|
|
2024
Q4 | USD 40.8 M | Comprar |
737,288
+33,445
| +5% | +USD 1.92 M | ﹤0.01% | 1835 |
|
|
2024
Q3 | USD 42 M | Comprar |
703,843
+58,698
| +9% | +USD 3.58 M | ﹤0.01% | 1792 |
|
|
2024
Q2 | USD 41.1 M | Comprar |
645,145
+70,307
| +12% | +USD 4.56 M | ﹤0.01% | 1770 |
|
|
2024
Q1 | USD 39.7 M | Vender |
574,838
-17,585
| -3% | -USD 1.06 M | ﹤0.01% | 1839 |
|
|
2023
Q4 | USD 32.7 M | Comprar |
592,423
+36,940
| +7% | +USD 2.03 M | ﹤0.01% | 1928 |
|
|
2023
Q3 | USD 32.3 M | Comprar |
555,483
+69,077
| +14% | +USD 3.99 M | ﹤0.01% | 1877 |
|
|
2023
Q2 | USD 26.2 M | Comprar |
486,406
+26,234
| +6% | +USD 1.16 M | ﹤0.01% | 2077 |
|
|
2023
Q1 | USD 18.3 M | Comprar |
460,172
+12,185
| +3% | +USD 514 k | ﹤0.01% | 2290 |
|
|
2022
Q4 | USD 18 M | Vender |
447,987
-5,493
| -1% | -USD 206 k | ﹤0.01% | 2316 |
|
|
2022
Q3 | USD 14.6 M | Vender |
453,480
-12,244
| -3% | -USD 419 k | ﹤0.01% | 2463 |
|
|
2022
Q2 | USD 13.8 M | Comprar |
465,724
+38,142
| +9% | +USD 1.1 M | ﹤0.01% | 2498 |
|
|
2022
Q1 | USD 12 M | Vender |
427,582
-9,998
| -2% | -USD 373 k | ﹤0.01% | 2720 |
|
|
2021
Q4 | USD 20.2 M | Comprar |
437,580
+26,560
| +6% | +USD 1.14 M | ﹤0.01% | 2467 |
|
|
2021
Q3 | USD 13.5 M | Comprar |
411,020
+10,985
| +3% | +USD 341 k | ﹤0.01% | 2706 |
|
|
2021
Q2 | USD 14 M | Comprar |
400,035
+5,043
| +1% | +USD 172 k | ﹤0.01% | 2714 |
|
|
2021
Q1 | USD 14.3 M | Comprar |
394,992
+80,083
| +25% | +USD 2.51 M | ﹤0.01% | 2558 |
|
|
2020
Q4 | USD 9.14 M | Comprar |
314,909
+12,572
| +4% | +USD 360 k | ﹤0.01% | 2681 |
|
|
2020
Q3 | USD 8.53 M | Vender |
302,337
-2,935
| -1% | -USD 87.4 k | ﹤0.01% | 2517 |
|
|
2020
Q2 | USD 9.9 M | Vender |
305,272
-20,081
| -6% | -USD 720 k | ﹤0.01% | 2427 |
|
|
2020
Q1 | USD 13.3 M | Comprar |
325,353
+15,490
| +5% | +USD 824 k | ﹤0.01% | 2089 |
|
|
2019
Q4 | USD 19.1 M | Comprar |
309,863
+7,029
| +2% | +USD 466 k | ﹤0.01% | 2159 |
|
|
2019
Q3 | USD 22.1 M | Comprar |
302,834
+14,069
| +5% | +USD 1.05 M | ﹤0.01% | 2001 |
|
|
2019
Q2 | USD 23.7 M | Comprar |
288,765
+23,653
| +9% | +USD 1.68 M | ﹤0.01% | 1997 |
|
|
2019
Q1 | USD 18.7 M | Comprar |
265,112
+23,714
| +10% | +USD 1.4 M | ﹤0.01% | 2089 |
|
|
2018
Q4 | USD 10.9 M | Vender |
241,398
-29,076
| -11% | -USD 1.52 M | ﹤0.01% | 2388 |
|
|
2018
Q3 | USD 15.3 M | Vender |
270,474
-6,002
| -2% | -USD 367 k | ﹤0.01% | 2355 |
|
|
2018
Q2 | USD 18.5 M | Vender |
276,476
-6,178
| -2% | -USD 386 k | ﹤0.01% | 2186 |
|
|
2018
Q1 | USD 16.5 M | Vender |
282,654
-1,586
| -0.6% | -USD 101 k | ﹤0.01% | 2186 |
|
|
2017
Q4 | USD 18.3 M | Comprar |
284,240
+12,647
| +5% | +USD 787 k | ﹤0.01% | 2107 |
|
|
2017
Q3 | USD 14.3 M | Vender |
271,593
-24,358
| -8% | -USD 1.16 M | ﹤0.01% | 2248 |
|
|
2017
Q2 | USD 13.8 M | Vender |
295,951
-8,044
| -3% | -USD 388 k | ﹤0.01% | 2226 |
|
|
2017
Q1 | USD 15 M | Vender |
303,995
-9,482
| -3% | -USD 532 k | ﹤0.01% | 2144 |
|
|
2016
Q4 | USD 19 M | Vender |
313,477
-25,466
| -8% | -USD 1.56 M | ﹤0.01% | 1937 |
|
|
2016
Q3 | USD 22.5 M | Comprar |
338,943
+47,504
| +16% | +USD 2.97 M | ﹤0.01% | 1702 |
|
|
2016
Q2 | USD 16.3 M | Comprar |
291,439
+112,076
| +62% | +USD 5.45 M | ﹤0.01% | 1902 |
|
|
2016
Q1 | USD 6.04 M | Vender |
179,363
-208,195
| -54% | -USD 7.06 M | ﹤0.01% | 2447 |
|
|
2015
Q4 | USD 17.5 M | Vender |
387,558
-247,465
| -39% | -USD 10.7 M | ﹤0.01% | 1809 |
|
|
2015
Q3 | USD 25.1 M | Vender |
635,023
-73,464
| -10% | -USD 4.18 M | ﹤0.01% | 1600 |
|
|
2015
Q2 | USD 44 M | Vender |
708,487
-10,759
| -1% | -USD 640 k | ﹤0.01% | 1349 |
|
|
2015
Q1 | USD 45 M | Comprar |
719,246
+303,152
| +73% | +USD 18.4 M | ﹤0.01% | 1295 |
|
|
2014
Q4 | USD 23.5 M | Comprar |
416,094
+338,278
| +435% | +USD 14.9 M | ﹤0.01% | 1685 |
|
|
2014
Q3 | USD 2.2 M | Comprar |
77,816
+5,940
| +8% | +USD 178 k | ﹤0.01% | 2971 |
|
|
2014
Q2 | USD 2.48 M | Comprar |
+71,876
| Nuevas | +USD 2.25 M | ﹤0.01% | 2964 |
|
|
2013
Q3 | – | Vender |
-2,173
| Cerradas | -USD 13 k | – | 3630 |
|
|
2013
Q2 | USD 13 k | Comprar |
+2,173
| Nuevas | +USD 15.2 k | ﹤0.01% | 3544 |
|
Otros fondos que tienen ANIP en su cartera
TCM
Posición de State Street en ANIP: resumen de T2 2026
State Street aumentó su participación en ANI Pharmaceuticals (ANIP) en 7.8% durante T2 2026, al comprar aproximadamente USD 4.82 M y elevar la posición a 831,647 acciones con un valor de USD 68.9 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1684.
State Street reportó por primera vez una posición en ANIP en T2 2013 y la ha mantenido durante 50 trimestres desde entonces. Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank mantienen una posición en ANIP.
- Al cierre de T2 2026, State Street tenía 831,647 acciones de ANI Pharmaceuticals con un valor de USD 68.9 M.
- State Street compró 60,060 acciones de ANI Pharmaceuticals en T2 2026, por un monto estimado de USD 4.82 M.
- ANI Pharmaceuticals representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 1684.
- State Street reportó por primera vez una posición en ANI Pharmaceuticals en T2 2013 y la ha mantenido durante 50 trimestres desde entonces.
- Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank tenían ANI Pharmaceuticals en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.